STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Bactiguard (STO:BACTIB) has entered a credit facility agreement of 130 million SEK in total. Combined with the company’s cash position, the credit facility secures the refinancing of Bactiguard’s bond loan, which matures in December 2016.
During the autumn, Bactiguard has been working on securing the refinancing of its bond loan. The income received in connection with the additional order from C.R. Bard has enabled the company to repurchase further bonds in the market and reduce the outstanding loan to 139 million SEK. Taking the cash position of 48.8 million SEK into account, the company’s net debt amounts to 91.6 million SEK as per 30 September. Today a credit facility of 130 million SEK in total was signed, which combined with the company’s cash position secures the refinancing of the bond loan when it expires in December 2016.
This is information that Bactiguard Holding AB (publ) is required to publish in compliance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on 10 November 2015, at 16.00.
Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company’s patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the Europe, Middle East, Asia, South America and Southern Africa. The company has market presence in some 50 countries and has about 60 employees. Its headquarters is located in Stockholm and production facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com
This information was brought to you by Cision http://news.cision.com